Haemonetics (HAE) Cash from Operations Growth (3y) (2012 - 2026)
Haemonetics (HAE) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 50.11% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.50% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -14.75% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn | -3.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -3.77% |
| Dec 27, 2025 | 13.25% |
| Sep 27, 2025 | 8.55% |
| Jun 28, 2025 | -25.46% |
| Mar 29, 2025 | 19.65% |
| Dec 28, 2024 | -11.17% |
| Sep 28, 2024 | 3.95% |
| Jun 29, 2024 | -153.66% |
| Mar 30, 2024 | 246.00% |
| Dec 30, 2023 | -26.16% |
| Sep 30, 2023 | 50.37% |
| Jul 1, 2023 | 17.34% |
| Apr 1, 2023 | 19.71% |
| Dec 31, 2022 | -6.69% |
| Oct 1, 2022 | 42.78% |
| Jul 2, 2022 | 151.87% |
| Apr 2, 2022 | 48.84% |
| Jan 1, 2022 | 2.39% |
| Oct 2, 2021 | -8.83% |
| Jul 3, 2021 | -27.50% |